Emily Fairbairn

Emily Fairbairn is a declared insider at 2 companies (board member); the most frequent names are Corvex, Inc. and In8bio, Inc. Between 23 March 2021 and 7 July 2026, the trades on record add up to 27 filings.

Every open-market trade on record is a purchase: 12 purchases worth €3.3M, and no sale. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 6 share grants and 1 option exercise.

Half of the purchases are above €124k and half below. 7 out of 12 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 8 July 2026: a transaction, in Corvex, Inc. The last purchase on record was published on 4 April 2024, which is 933 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.